Search

Author/Creator Vahdat, Linda T.

1. A phase IIA trial of acupuncture to reduce chemotherapy-induced peripheral neuropathy severity during neoadjuvant or adjuvant weekly paclitaxel chemotherapy in breast cancer patients. (September 2018)

Authors:
Bao, Ting; Seidman, Andrew D.; Piulson, Lauren; Vertosick, Emily; Chen, Xi; Vickers, Andrew J.; Blinder, Victoria S.; Zhi, Wanqing I.; Li, Qing; Vahdat, Linda T.; Dickler, Maura N.; Robson, Mark E.; Mao, Jun J.
Journal:
European journal of cancer
Issue:
Volume 101(2018)
Page Start:
12
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Ixabepilone‐induced mitochondria and sensory axon loss in breast cancer patients. (2nd September 2014)

Authors:
Ebenezer, Gigi J.; Carlson, Karen; Donovan, Diana; Cobham, Marta; Chuang, Ellen; Moore, Anne; Cigler, Tessa; Ward, Maureen; Lane, Maureen E.; Ramnarain, Anita; Vahdat, Linda T.; Polydefkis, Michael
Journal:
Annals of clinical and translational neurology
Issue:
Volume 1:Number 9(2014)
Page Start:
639
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Personalized Nutrition in Disrupting Cancer — Proceedings From the 2017 American College of Nutrition Annual Meeting. (2nd January 2019)

Authors:
Wallace, Taylor C.; Bultman, Scott; D'Adamo, Chris; Daniel, Carrie R.; Debelius, Justine; Ho, Emily; Eliassen, Heather; Lemanne, Dawn; Mukherjee, Purna; Seyfried, Thomas N.; Tian, Qiang; Vahdat, Linda T.
Journal:
Journal of the American College of Nutrition
Issue:
Volume 38:Number 1(2019)
Page Start:
1
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Randomized Phase II Study of Ramucirumab or Icrucumab in Combination with Capecitabine in Patients with Previously Treated Locally Advanced or Metastatic Breast Cancer. (20th February 2017)

Authors:
Vahdat, Linda T.; Layman, Rachel; Yardley, Denise A.; Gradishar, William; Salkeni, Mohamad A.; Joy, Anil Abraham; Garcia, Agustin A.; Ward, Patrick; Khatcheressian, James; Sparano, Joseph; Rodriguez, Gladys; Tang, Shande; Gao, Ling; Dalal, Rita P.; Kauh, John; Miller, Kathy
Journal:
Oncologist
Issue:
Volume 22:Number 3(2017)
Page Start:
245
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. Randomized Phase II Study of Ramucirumab or Icrucumab in Combination with Capecitabine in Patients with Previously Treated Locally Advanced or Metastatic Breast Cancer. (March 2017)

Authors:
Vahdat, Linda T.; Layman, Rachel; Yardley, Denise A.; Gradishar, William; Salkeni, Mohamad A.; Abraham Joy, Anil; Garcia, Agustin A.; Ward, Patrick; Khatcheressian, James; Sparano, Joseph; Rodriguez, Gladys; Tang, Shande; Gao, Ling; Dalal, Rita P.; Kauh, John; Miller, Kathy
Journal:
Oncologist
Issue:
Volume 22:Number 3(2017)
Page Start:
245
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

7. Sacituzumab govitecan (IMMU‐132), an anti‐Trop‐2‐SN‐38 antibody‐drug conjugate for the treatment of diverse epithelial cancers: Safety and pharmacokinetics. Issue 19 (30th May 2017)

Authors:
Ocean, Allyson J.; Starodub, Alexander N.; Bardia, Aditya; Vahdat, Linda T.; Isakoff, Steven J.; Guarino, Michael; Messersmith, Wells A.; Picozzi, Vincent J.; Mayer, Ingrid A.; Wegener, William A.; Maliakal, Pius; Govindan, Serengulam V.; Sharkey, Robert M.; Goldenberg, David M.
Journal:
Cancer
Issue:
Volume 123:Issue 19(2017)
Page Start:
3843
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗